118 related articles for article (PubMed ID: 3017902)
1. DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphisms.
Segall M; Noreen H; Schluender L; Swenson M; Barbosa J; Bach FH
Hum Immunol; 1986 Sep; 17(1):61-8. PubMed ID: 3017902
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.
Cohen N; Brautbar C; Font MP; Dausset J; Cohen D
Immunogenetics; 1986; 23(2):84-9. PubMed ID: 3007344
[TBL] [Abstract][Full Text] [Related]
3. Insulin-dependent diabetes--associated HLA-D region encoded determinants.
Bach FH; Rich SS; Barbosa J; Segall M
Hum Immunol; 1985 Feb; 12(2):59-64. PubMed ID: 3871432
[TBL] [Abstract][Full Text] [Related]
4. DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2.
Segall M; Noreen H; Schluender L; Bach FH
Hum Immunol; 1986 Mar; 15(3):336-43. PubMed ID: 3007406
[TBL] [Abstract][Full Text] [Related]
5. A study of HLA-DR2 associated HLA-Dw/LD specificities.
Reinsmoen NL; Layrisse Z; Betuel H; Freidel AC; Bach FH
Hum Immunol; 1984 Oct; 11(2):105-15. PubMed ID: 6208174
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.
Haegert DG; Michaud M; Schwab C; Tansey C; Décary F; Francis G
J Neurosci Res; 1989 May; 23(1):46-54. PubMed ID: 2568496
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of a recombinant HLA-DR1/DR2 haplotype.
Bidwell JL; Bidwell EA; Dupont E; Andrien M; Bouillenne C; Klouda PT; Bradley BA
Hum Immunol; 1992 Apr; 33(4):289-93. PubMed ID: 1353488
[TBL] [Abstract][Full Text] [Related]
8. DNA restriction fragment length polymorphism of HLA-DR2: correlation with HLA-DR2-associated functions.
Jacobson S; Sorrentino R; Nepom GT; McFarlin DE; Strominger JL
J Neuroimmunol; 1986 Sep; 12(3):195-203. PubMed ID: 3016025
[TBL] [Abstract][Full Text] [Related]
9. Restriction fragment length polymorphism (RFLP) heterogeneity of HLA-DQ beta genes associated with DNA fragment identical to the DR1-beta DNA structure.
Redford A; Magalong D; Onohara-Toyoda M; Tyan D; Riley WJ; Maclaren NK; Rotter JI; Toyoda H
Dis Markers; 1991; 9(5):257-63. PubMed ID: 1686750
[TBL] [Abstract][Full Text] [Related]
10. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. A study at the serological and genomic level.
Wilner A; Steinman L; Lavie P; Peled R; Friedmann A; Brautbar C
Hum Immunol; 1988 Jan; 21(1):15-22. PubMed ID: 2896649
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
12. Protein analysis of HLA-DR2.3 haplotype.
Yabe T; Reinsmoen NL; Wu S; Bach FH
Hum Immunol; 1987 Jun; 19(2):127-37. PubMed ID: 3497139
[TBL] [Abstract][Full Text] [Related]
13. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
Liu CP; Bach FH; Wu SK
J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
[TBL] [Abstract][Full Text] [Related]
14. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
15. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.
Cohen D; Cohen O; Marcadet A; Massart C; Lathrop M; Deschamps I; Hors J; Schuller E; Dausset J
Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1774-8. PubMed ID: 6324215
[TBL] [Abstract][Full Text] [Related]
16. Increasing complexity of HLA-DR2 as detected by serology and oligonucleotide typing.
Schreuder GM; van den Berg-Loonen PM; Verduyn W; Geraets DP; Parlevliet J; van Rood JJ; Giphart MJ
Hum Immunol; 1991 Oct; 32(2):141-9. PubMed ID: 1683866
[TBL] [Abstract][Full Text] [Related]
17. An allelic cluster of DQ alpha restriction fragments is associated with multiple sclerosis: evidence that a second haplotype may influence disease susceptibility.
Heard RN; Cullen C; Middleton D; Hawkins SA; Francis DA; Hern JE; McDonald WI; Batchelor JR; Lechler RI
Hum Immunol; 1989 Jun; 25(2):111-23. PubMed ID: 2567726
[TBL] [Abstract][Full Text] [Related]
18. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.
Böhme J; Carlsson B; Wallin J; Möller E; Persson B; Peterson PA; Rask L
J Immunol; 1986 Aug; 137(3):941-7. PubMed ID: 2424992
[TBL] [Abstract][Full Text] [Related]
19. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals.
Tilanus MG; Morolli B; van Eggermond MC; Schreuder GM; de Vries RR; Giphart MJ
Immunogenetics; 1986; 23(5):333-40. PubMed ID: 3011659
[TBL] [Abstract][Full Text] [Related]
20. Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients.
Zeliszewski D; Tiercy JM; Boitard C; Gu XF; Loche M; Krishnamoorthy R; Simonney N; Elion J; Bach JF; Mach B
Hum Immunol; 1992 Feb; 33(2):140-7. PubMed ID: 1348743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
